0001437749-18-016812.txt : 20180910
0001437749-18-016812.hdr.sgml : 20180910
20180910163029
ACCESSION NUMBER: 0001437749-18-016812
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180907
FILED AS OF DATE: 20180910
DATE AS OF CHANGE: 20180910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wrighton-Smith Peter
CENTRAL INDEX KEY: 0001592286
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 181063109
MAIL ADDRESS:
STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC
STREET 2: 94C INNOVATION DRIVE
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
rdgdoc.xml
FORM 4
X0306
4
2018-09-07
0001586049
Oxford Immunotec Global PLC
OXFD
0001592286
Wrighton-Smith Peter
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
1
Chief Executive Officer
Ordinary Shares
2018-09-07
4
M
0
40000
0.81
A
525296
D
Ordinary Shares
2018-09-07
4
S
0
40000
14.95
D
485296
D
Stock Option (Right to Buy)
0.81
2018-09-07
4
M
0
40000
0
D
2022-12-31
Ordinary Shares
40000
54273
D
The original exercise price of these options was priced in GBP at GBP0.51 and converted to US$ at an exchange rate of US$1.58823=1GBP.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2015, as amended.
Exercise from an option granted November 7, 2012, which became fully vested on December 31, 2016.
/s/ Elizabeth M. Keiley, as Attorney-in-Fact for Peter Wrighton-Smith
2018-09-10